img

Global Diagnostic Nuclear Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Diagnostic Nuclear Drug Market Insights, Forecast to 2034

Nuclear Drugs are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
Market Analysis and InsightsGlobal Diagnostic Nuclear Drug Market
Global Diagnostic Nuclear Drug market is expected to reach to US$ 5049 million in 2024, with a positive growth of %, compared with US$ 4722 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Diagnostic Nuclear Drug industry is evaluated to reach US$ 7534.8 million in 2029. The CAGR will be 6.9% during 2024 to 2029.
The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.
Report Covers
This report presents an overview of global Diagnostic Nuclear Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Diagnostic Nuclear Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Novartis
SIEMENS
China Isotope & Radiation
Dongcheng
Lantheus
Eli Lilly
Segment by Type
Tc-99m
F-18
Other

Segment by Application


Oncology
Cardiology
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Diagnostic Nuclear Drug introduction, etc. Diagnostic Nuclear Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Diagnostic Nuclear Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tc-99m
1.2.3 F-18
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diagnostic Nuclear Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diagnostic Nuclear Drug Market Perspective (2018-2029)
2.2 Global Diagnostic Nuclear Drug Growth Trends by Region
2.2.1 Diagnostic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Diagnostic Nuclear Drug Historic Market Size by Region (2018-2024)
2.2.3 Diagnostic Nuclear Drug Forecasted Market Size by Region (2024-2029)
2.3 Diagnostic Nuclear Drug Market Dynamics
2.3.1 Diagnostic Nuclear Drug Industry Trends
2.3.2 Diagnostic Nuclear Drug Market Drivers
2.3.3 Diagnostic Nuclear Drug Market Challenges
2.3.4 Diagnostic Nuclear Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Diagnostic Nuclear Drug by Players
3.1.1 Global Diagnostic Nuclear Drug Revenue by Players (2018-2024)
3.1.2 Global Diagnostic Nuclear Drug Revenue Market Share by Players (2018-2024)
3.2 Global Diagnostic Nuclear Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Diagnostic Nuclear Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Diagnostic Nuclear Drug Market Concentration Ratio
3.4.1 Global Diagnostic Nuclear Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Nuclear Drug Revenue in 2022
3.5 Global Key Players of Diagnostic Nuclear Drug Head office and Area Served
3.6 Global Key Players of Diagnostic Nuclear Drug, Product and Application
3.7 Global Key Players of Diagnostic Nuclear Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Diagnostic Nuclear Drug Breakdown Data by Type
4.1 Global Diagnostic Nuclear Drug Historic Market Size by Type (2018-2024)
4.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2024-2029)
5 Diagnostic Nuclear Drug Breakdown Data by Application
5.1 Global Diagnostic Nuclear Drug Historic Market Size by Application (2018-2024)
5.2 Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Diagnostic Nuclear Drug Market Size (2018-2029)
6.2 North America Diagnostic Nuclear Drug Market Size by Type
6.2.1 North America Diagnostic Nuclear Drug Market Size by Type (2018-2024)
6.2.2 North America Diagnostic Nuclear Drug Market Size by Type (2024-2029)
6.2.3 North America Diagnostic Nuclear Drug Market Share by Type (2018-2029)
6.3 North America Diagnostic Nuclear Drug Market Size by Application
6.3.1 North America Diagnostic Nuclear Drug Market Size by Application (2018-2024)
6.3.2 North America Diagnostic Nuclear Drug Market Size by Application (2024-2029)
6.3.3 North America Diagnostic Nuclear Drug Market Share by Application (2018-2029)
6.4 North America Diagnostic Nuclear Drug Market Size by Country
6.4.1 North America Diagnostic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Diagnostic Nuclear Drug Market Size by Country (2018-2024)
6.4.3 North America Diagnostic Nuclear Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Diagnostic Nuclear Drug Market Size (2018-2029)
7.2 Europe Diagnostic Nuclear Drug Market Size by Type
7.2.1 Europe Diagnostic Nuclear Drug Market Size by Type (2018-2024)
7.2.2 Europe Diagnostic Nuclear Drug Market Size by Type (2024-2029)
7.2.3 Europe Diagnostic Nuclear Drug Market Share by Type (2018-2029)
7.3 Europe Diagnostic Nuclear Drug Market Size by Application
7.3.1 Europe Diagnostic Nuclear Drug Market Size by Application (2018-2024)
7.3.2 Europe Diagnostic Nuclear Drug Market Size by Application (2024-2029)
7.3.3 Europe Diagnostic Nuclear Drug Market Share by Application (2018-2029)
7.4 Europe Diagnostic Nuclear Drug Market Size by Country
7.4.1 Europe Diagnostic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Diagnostic Nuclear Drug Market Size by Country (2018-2024)
7.4.3 Europe Diagnostic Nuclear Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Diagnostic Nuclear Drug Market Size (2018-2029)
8.2 China Diagnostic Nuclear Drug Market Size by Type
8.2.1 China Diagnostic Nuclear Drug Market Size by Type (2018-2024)
8.2.2 China Diagnostic Nuclear Drug Market Size by Type (2024-2029)
8.2.3 China Diagnostic Nuclear Drug Market Share by Type (2018-2029)
8.3 China Diagnostic Nuclear Drug Market Size by Application
8.3.1 China Diagnostic Nuclear Drug Market Size by Application (2018-2024)
8.3.2 China Diagnostic Nuclear Drug Market Size by Application (2024-2029)
8.3.3 China Diagnostic Nuclear Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Diagnostic Nuclear Drug Market Size (2018-2029)
9.2 Asia Diagnostic Nuclear Drug Market Size by Type
9.2.1 Asia Diagnostic Nuclear Drug Market Size by Type (2018-2024)
9.2.2 Asia Diagnostic Nuclear Drug Market Size by Type (2024-2029)
9.2.3 Asia Diagnostic Nuclear Drug Market Share by Type (2018-2029)
9.3 Asia Diagnostic Nuclear Drug Market Size by Application
9.3.1 Asia Diagnostic Nuclear Drug Market Size by Application (2018-2024)
9.3.2 Asia Diagnostic Nuclear Drug Market Size by Application (2024-2029)
9.3.3 Asia Diagnostic Nuclear Drug Market Share by Application (2018-2029)
9.4 Asia Diagnostic Nuclear Drug Market Size by Region
9.4.1 Asia Diagnostic Nuclear Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Diagnostic Nuclear Drug Market Size by Region (2018-2024)
9.4.3 Asia Diagnostic Nuclear Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Cardinal Health
11.1.1 Cardinal Health Company Details
11.1.2 Cardinal Health Business Overview
11.1.3 Cardinal Health Diagnostic Nuclear Drug Introduction
11.1.4 Cardinal Health Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.1.5 Cardinal Health Recent Developments
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Diagnostic Nuclear Drug Introduction
11.2.4 GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.2.5 GE Healthcare Recent Developments
11.3 Curium Pharma
11.3.1 Curium Pharma Company Details
11.3.2 Curium Pharma Business Overview
11.3.3 Curium Pharma Diagnostic Nuclear Drug Introduction
11.3.4 Curium Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.3.5 Curium Pharma Recent Developments
11.4 Jubilant Pharma
11.4.1 Jubilant Pharma Company Details
11.4.2 Jubilant Pharma Business Overview
11.4.3 Jubilant Pharma Diagnostic Nuclear Drug Introduction
11.4.4 Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.4.5 Jubilant Pharma Recent Developments
11.5 Bracco Imaging
11.5.1 Bracco Imaging Company Details
11.5.2 Bracco Imaging Business Overview
11.5.3 Bracco Imaging Diagnostic Nuclear Drug Introduction
11.5.4 Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.5.5 Bracco Imaging Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Diagnostic Nuclear Drug Introduction
11.6.4 Novartis Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.6.5 Novartis Recent Developments
11.7 SIEMENS
11.7.1 SIEMENS Company Details
11.7.2 SIEMENS Business Overview
11.7.3 SIEMENS Diagnostic Nuclear Drug Introduction
11.7.4 SIEMENS Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.7.5 SIEMENS Recent Developments
11.8 China Isotope & Radiation
11.8.1 China Isotope & Radiation Company Details
11.8.2 China Isotope & Radiation Business Overview
11.8.3 China Isotope & Radiation Diagnostic Nuclear Drug Introduction
11.8.4 China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.8.5 China Isotope & Radiation Recent Developments
11.9 Dongcheng
11.9.1 Dongcheng Company Details
11.9.2 Dongcheng Business Overview
11.9.3 Dongcheng Diagnostic Nuclear Drug Introduction
11.9.4 Dongcheng Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.9.5 Dongcheng Recent Developments
11.10 Lantheus
11.10.1 Lantheus Company Details
11.10.2 Lantheus Business Overview
11.10.3 Lantheus Diagnostic Nuclear Drug Introduction
11.10.4 Lantheus Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.10.5 Lantheus Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Company Details
11.11.2 Eli Lilly Business Overview
11.11.3 Eli Lilly Diagnostic Nuclear Drug Introduction
11.11.4 Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2018-2024)
11.11.5 Eli Lilly Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Tc-99m
Table 3. Key Players of F-18
Table 4. Key Players of Other
Table 5. Global Diagnostic Nuclear Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Diagnostic Nuclear Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Diagnostic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Diagnostic Nuclear Drug Market Share by Region (2018-2024)
Table 9. Global Diagnostic Nuclear Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Diagnostic Nuclear Drug Market Share by Region (2024-2029)
Table 11. Diagnostic Nuclear Drug Market Trends
Table 12. Diagnostic Nuclear Drug Market Drivers
Table 13. Diagnostic Nuclear Drug Market Challenges
Table 14. Diagnostic Nuclear Drug Market Restraints
Table 15. Global Diagnostic Nuclear Drug Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Diagnostic Nuclear Drug Revenue Share by Players (2018-2024)
Table 17. Global Top Diagnostic Nuclear Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2022)
Table 18. Global Diagnostic Nuclear Drug Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Diagnostic Nuclear Drug Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Diagnostic Nuclear Drug, Headquarters and Area Served
Table 21. Global Key Players of Diagnostic Nuclear Drug, Product and Application
Table 22. Global Key Players of Diagnostic Nuclear Drug, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2018-2024)
Table 26. Global Diagnostic Nuclear Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Diagnostic Nuclear Drug Revenue Market Share by Type (2024-2029)
Table 28. Global Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Diagnostic Nuclear Drug Revenue Share by Application (2018-2024)
Table 30. Global Diagnostic Nuclear Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Diagnostic Nuclear Drug Revenue Share by Application (2024-2029)
Table 32. North America Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Diagnostic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Diagnostic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Diagnostic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Diagnostic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Diagnostic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Diagnostic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Diagnostic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Diagnostic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Diagnostic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Diagnostic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Diagnostic Nuclear Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Diagnostic Nuclear Drug Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Diagnostic Nuclear Drug Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size by Country (2024-2029) & (US$ Million)
Table 64. Cardinal Health Company Details
Table 65. Cardinal Health Business Overview
Table 66. Cardinal Health Diagnostic Nuclear Drug Product
Table 67. Cardinal Health Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 68. Cardinal Health Recent Developments
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Diagnostic Nuclear Drug Product
Table 72. GE Healthcare Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 73. GE Healthcare Recent Developments
Table 74. Curium Pharma Company Details
Table 75. Curium Pharma Business Overview
Table 76. Curium Pharma Diagnostic Nuclear Drug Product
Table 77. Curium Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 78. Curium Pharma Recent Developments
Table 79. Jubilant Pharma Company Details
Table 80. Jubilant Pharma Business Overview
Table 81. Jubilant Pharma Diagnostic Nuclear Drug Product
Table 82. Jubilant Pharma Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 83. Jubilant Pharma Recent Developments
Table 84. Bracco Imaging Company Details
Table 85. Bracco Imaging Business Overview
Table 86. Bracco Imaging Diagnostic Nuclear Drug Product
Table 87. Bracco Imaging Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 88. Bracco Imaging Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis Diagnostic Nuclear Drug Product
Table 92. Novartis Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. SIEMENS Company Details
Table 95. SIEMENS Business Overview
Table 96. SIEMENS Diagnostic Nuclear Drug Product
Table 97. SIEMENS Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 98. SIEMENS Recent Developments
Table 99. China Isotope & Radiation Company Details
Table 100. China Isotope & Radiation Business Overview
Table 101. China Isotope & Radiation Diagnostic Nuclear Drug Product
Table 102. China Isotope & Radiation Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 103. China Isotope & Radiation Recent Developments
Table 104. Dongcheng Company Details
Table 105. Dongcheng Business Overview
Table 106. Dongcheng Diagnostic Nuclear Drug Product
Table 107. Dongcheng Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 108. Dongcheng Recent Developments
Table 109. Lantheus Company Details
Table 110. Lantheus Business Overview
Table 111. Lantheus Diagnostic Nuclear Drug Product
Table 112. Lantheus Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 113. Lantheus Recent Developments
Table 114. Eli Lilly Company Details
Table 115. Eli Lilly Business Overview
Table 116. Eli Lilly Diagnostic Nuclear Drug Product
Table 117. Eli Lilly Revenue in Diagnostic Nuclear Drug Business (2018-2024) & (US$ Million)
Table 118. Eli Lilly Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Nuclear Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Diagnostic Nuclear Drug Market Share by Type: 2022 VS 2029
Figure 3. Tc-99m Features
Figure 4. F-18 Features
Figure 5. Other Features
Figure 6. Global Diagnostic Nuclear Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Diagnostic Nuclear Drug Market Share by Application: 2022 VS 2029
Figure 8. Oncology Case Studies
Figure 9. Cardiology Case Studies
Figure 10. Other Case Studies
Figure 11. Diagnostic Nuclear Drug Report Years Considered
Figure 12. Global Diagnostic Nuclear Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Diagnostic Nuclear Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Diagnostic Nuclear Drug Market Share by Region: 2022 VS 2029
Figure 15. Global Diagnostic Nuclear Drug Market Share by Players in 2022
Figure 16. Global Top Diagnostic Nuclear Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Nuclear Drug as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Diagnostic Nuclear Drug Revenue in 2022
Figure 18. North America Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Diagnostic Nuclear Drug Market Share by Type (2018-2029)
Figure 20. North America Diagnostic Nuclear Drug Market Share by Application (2018-2029)
Figure 21. North America Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 22. United States Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Diagnostic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Diagnostic Nuclear Drug Market Share by Type (2018-2029)
Figure 26. Europe Diagnostic Nuclear Drug Market Share by Application (2018-2029)
Figure 27. Europe Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 28. Germany Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Diagnostic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Diagnostic Nuclear Drug Market Share by Type (2018-2029)
Figure 36. China Diagnostic Nuclear Drug Market Share by Application (2018-2029)
Figure 37. Asia Diagnostic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Diagnostic Nuclear Drug Market Share by Type (2018-2029)
Figure 39. Asia Diagnostic Nuclear Drug Market Share by Application (2018-2029)
Figure 40. Asia Diagnostic Nuclear Drug Market Share by Region (2018-2029)
Figure 41. Japan Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Diagnostic Nuclear Drug Market Share by Country (2018-2029)
Figure 51. Brazil Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Diagnostic Nuclear Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Cardinal Health Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 58. GE Healthcare Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 59. Curium Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 60. Jubilant Pharma Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 61. Bracco Imaging Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 62. Novartis Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 63. SIEMENS Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 64. China Isotope & Radiation Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 65. Dongcheng Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 66. Lantheus Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 67. Eli Lilly Revenue Growth Rate in Diagnostic Nuclear Drug Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries